Retractable Technologies (RVP) Capital Expenditures (2010 - 2026)
Retractable Technologies' (RVP) quarterly Capital Expenditures came in at $29823.0 in Q2 2026, down 91.02% on a YoY basis from $332250.0 in Q2 2025, and up 378.93% quarter-over-quarter from $6227.0 in Q1 2026.
Analysis
Retractable Technologies (RVP) Capital Expenditures (2010 - 2026) Analysis & Trends
Retractable Technologies (RVP) has reported Capital Expenditures for 17 consecutive years, with $29823.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Capital Expenditures fell 91.02% year-over-year to $29823.0; the trailing twelve-month figure through Jun 2026 stood at $152410.0 (down 89.91% YoY), and the FY2025 full-year result was $535644.0, down 62.8% from the prior year.
- Capital Expenditures improved to $29823.0 in Q2 2026 per RVP's latest filing, from $6227.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $5.6 million in Q2 2022 and bottomed at $6227.0 in Q1 2026.
- Historically, Capital Expenditures has averaged $1.1 million across 5 years, with a median of $190046.0 in 2023.
- The sharpest annual moves came in 2023 and 2024: Capital Expenditures tumbled 98.41% in 2023, then jumped 455.49% in 2024.
- Over 5 years, Capital Expenditures stood at $2.9 million in 2022, then slumped by 94.79% to $153696.0 in 2023, then jumped by 93.93% to $298058.0 in 2024, then sank by 91.08% to $26572.0 in 2025, then climbed by 12.23% to $29823.0 in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered $29823.0, $6227.0, and $26572.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 48.41 Bn | 47.55 Bn | 2.32 Bn | 143.00 Mn |
| 2 | Medline | 27.78 Bn | 25.10 Bn | 2.22 Bn | 111.00 Mn |
| 3 | West Pharmaceutical Services | 24.42 Bn | 23.98 Bn | 329.20 Mn | 43.20 Mn |
| 4 | Baxter International | 12.49 Bn | 10.34 Bn | 1.03 Bn | 116.00 Mn |
| 5 | Stevanato Group S.p.A | 5.70 Bn | 5.59 Bn | 100.91 Mn | -67.01 Mn |
| 6 | Acme United | 235.29 Mn | 230.25 Mn | 26.69 Mn | 1.07 Mn |
| 7 | Rockwell Medical | 31.39 Mn | 6.60 Mn | 3.24 Mn | 617,000.00 |
| 8 | Retractable Technologies | 21.15 Mn | -18.72 Mn | 190,852.00 | 29,823.00 |
| 9 | United Health Products | 8.85 Mn | 8.82 Mn | - | - |
| 10 | Cuprina Holdings (Cayman) | 7.88 Mn | 4.76 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29,823.00 |
| Mar 31, 2026 | 6,227.00 |
| Dec 31, 2025 | 26,572.00 |
| Sep 30, 2025 | 89,788.00 |
| Jun 30, 2025 | 332,250.00 |
| Mar 31, 2025 | 87,034.00 |
| Dec 31, 2024 | 298,058.00 |
| Sep 30, 2024 | 793,785.00 |
| Jun 30, 2024 | 121,704.00 |
| Mar 31, 2024 | 226,396.00 |
| Dec 31, 2023 | 153,696.00 |
| Sep 30, 2023 | 142,898.00 |
| Jun 30, 2023 | 88,855.00 |
| Mar 31, 2023 | 467,530.00 |
| Dec 31, 2022 | 2.95 Mn |
| Sep 30, 2022 | 3.34 Mn |
| Jun 30, 2022 | 5.57 Mn |
| Mar 31, 2022 | 4.97 Mn |
| Dec 31, 2021 | 11.85 Mn |
| Sep 30, 2021 | 8.36 Mn |